Feasibility of Point-of-Care Genomic Profiling in the Diagnosis and Treatment of Cancer of Unknown Primary

INTRODUCTION: Cancer of unknown primary remains a challenging clinical entity. Despite receiving empiric chemotherapy, median overall survival is approximately 6-12 months. Site-specific therapy based on molecular characterization has been shown to improve outcomes; however, feasibility outside of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Beharry, Andrea, Sheffield, Brandon S, Cheema, Parneet K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243757/
https://www.ncbi.nlm.nih.gov/pubmed/36933203
http://dx.doi.org/10.1093/oncolo/oyad054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243757/
https://www.ncbi.nlm.nih.gov/pubmed/36933203
http://dx.doi.org/10.1093/oncolo/oyad054

Ejemplares similares